On Invalid Date, Merck & Co (NYSE: MRK) reported Q4 2023 earnings per share (EPS) of -$0.49, up 141.53% year over year. Total Merck & Co earnings for the quarter were -$1.23 billion. In the same quarter last year, Merck & Co's earnings per share (EPS) was $1.18.
As of Q2 2024, Merck & Co's earnings has grown -97.56% year over year. This is 97.69 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 0.14%. Merck & Co's earnings in the past year totalled $365.00 million.
What was MRK's revenue last quarter?
On Invalid Date, Merck & Co (NYSE: MRK) reported Q4 2023 revenue of $14.63 billion up 5.78% year over year. In the same quarter last year, Merck & Co's revenue was $13.83 billion.
What was MRK's revenue growth in the past year?
As of Q2 2024, Merck & Co's revenue has grown 1.4% year over year. This is 3.21 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 4.62%. Merck & Co's revenue in the past year totalled $60.12 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.